0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vaccine Adjuvant"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,950USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Vaccine Adjuvants - Global Strategic Business Report - Product Thumbnail Image

Vaccine Adjuvants - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
EUR$5,850USDGBP
Vaccine Adjuvants Market Report 2025 - Product Thumbnail Image

Vaccine Adjuvants Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$2,999USDGBP
From
EUR$3,750USDGBP
From
EUR$4,500USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
Vaccine Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Vaccine Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 400 Pages
  • Global
From
EUR$3,995USDGBP
Loading Indicator

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus. Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more